- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
U.S. top 20 prescribed drugs based on sales 2016
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
U.S. top 20 prescribed drugs based on sales 2016
Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*
This statistic depicts the U.S. top 20 prescription drugs based on total sales in 2016. In that year, Harvoni generated some 10 billion U.S. dollars in sales. Thus, Harvoni was the second ranked drug in the United States based on revenue. Harvoni is manufactured by Gilead Sciences, a U.S. biotech company headquartered in Foster City, California.
Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*
| Drug (Company) | Sales in billion U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| Drug (Company) | Sales in billion U.S. dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
This statistic depicts the U.S. top 20 prescription drugs based on total sales in 2016. In that year, Harvoni generated some 10 billion U.S. dollars in sales. Thus, Harvoni was the second ranked drug in the United States based on revenue. Harvoni is manufactured by Gilead Sciences, a U.S. biotech company headquartered in Foster City, California.
Show more- Show sources information
- Show publisher information
- Release date
- May 2017
- Region
- United States
- Survey time period
- 2016
- Supplementary notes
- * Non-discounted spending.
- Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- May 2017
More information
- Region
- United States
- Survey time period
- 2016
- Supplementary notes
- * Non-discounted spending.
- Open this statistic in...
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Pharmaceutical brands: Abilify (BMS/Otsuka)
- 27 page/s
- English
- pptx
- Detailed references
Everything On "Pharmaceutical brands: Abilify (BMS/Otsuka)" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "U.S. pharmaceutical industry"
- Contribution to global pharma
The most important statistics
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*World pharmaceutical market distribution by submarket 2014-2018
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*World pharmaceutical sales 2016-2018 by region
- Market share of top 10 national pharmaceutical markets worldwide in 2017*Market share of the leading 10 global pharmaceutical markets 2017
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2017
- Leading countries in global life sciences mergers and acquisitions based on deal number in 2018Leading countries in life sciences sector M&As 2018
- Overview
The most important statistics
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*U.S. total medicine spending 2002-2016
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)Leading therapy areas for U.S. drug spending 2016
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*U.S. top 20 prescribed drugs based on sales 2016
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)Top U.S. pharma products by prescriptions 2016
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)Pharmaceutical channel distribution by U.S. spending 2014-2016
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*Pharmaceutical preparation manufacturing gross output 1998-2016
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
- Companies
The most important statistics
- 2018 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*2018 list of top U.S. biotech and pharmaceutical companies based on revenue
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*Pharmaceutical corporations by U.S. revenue 2016
- Johnson & Johnson's total revenue from 2005 to 2018 (in million U.S. dollars)Johnson & Johnson's total revenue 2005-2018
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)Pfizer's total revenue 2006-2018
- Total revenue of Merck & Co. from 2006 to 2018 (in million U.S. dollars)Merck & Co - total revenue 2006-2018
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)Ad spending of pharmaceutical companies in the U.S. 2015
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*Highest pharmaceutical company penalties in the U.S. 2012-2015
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)Top pharmaceutical companies located in Canada by revenue 2016
- Research and development
The most important statistics
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*Research and development expenditure: U.S. pharmaceutical industry 1995-2017
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017U.S. pharma industry R&D spending as a percent of total revenues 1990-2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*Pharmaceuticals: biopharma medicines in development 2018 by category
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*Pharmaceuticals: cost of drug development in the U.S. since 1975
- Number of new molecular entities launched in the U.S. from 2003 to 2015Number of new drugs launched in the U.S. 2003-2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014Number of FDA approved orphan designations in the U.S. 2000-2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)U.S. sales growth of new brand medicines 2011-2015
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2014R&D expenditure per employee in U.S. sectors 2000-2014
- Generics
The most important statistics
- Change in branded and generic medication spending in the United States from 2013 to 2017 (in billion U.S. dollars)*Spending change on branded and generic medicines in the U.S. 2013-2017
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016U.S. brand and generic prescription drug revenue 2005-2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016Branded vs. generic U.S. drug prescriptions dispensed 2005-2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)Savings through generic drug usage in the U.S. 2008-2017
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*Biggest selling drugs with patent at threat in the U.S. in 2017, by revenue
- Outlook
The most important statistics
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by regionForecast of CAGR global pharmaceutical industry by region 2015-2018
- Forecast of global medicine spending distribution in 2020, by region*Global spending on medicines by regional share forecast 2020
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2022
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*Top branded biologic drugs in the U.S. that will go generic by 2028
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)Leading U.S. pharmaceutical products by revenue 2024
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2019 (in billion U.S. dollars)Healthcare and pharmaceutical industry digital ad spend in the U.S. 2011-2019
- The consumer's view
The most important statistics
- How is your overall impression of the U.S. pharma industry?U.S. adults impression of the U.S. pharma industry
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?U.S. adults that believe physicians are under pressure from pharma to prescribe drugs
- How would you rate the U.S. pharma companies concerning the quality of their drugs?U.S. adults impression of the U.S. pharma drug qualities
- How would you rate the U.S. pharma companies concerning their fairness towards patients?U.S. adults impression of the U.S. pharma companies fairness towards patients
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017U.S. adults who would rate selected pharma features as excellent or good 2017
- Which of these pharma companies do you prefer when buying drugs?Preferred pharma companies by Americans for drug purchase 2017
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*Americans on US pharma quality compared to foreign pharma 2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- U.S. top 10 prescribed drugs based on market share 2016
- Value of expiring patents in U.S. 2016-2019
- Americans' impression of the US pharma industry quality of drugs, by ethnicity 2017
- Rate of price change for patented drugs 2017, by country
- Quantity change of patented drugs in Canada by therapy class 2015-2016
- Canada 's global sales share of patented drugs 2005-2017
- Sales growth changes of patented drugs in Canada 2017
- Patented drug 2017 sales share distribution by year of product introduction
- Patent drug sales impact on change in expenditure by therapy class in Canada 2017
- Total U.S. population with usage of prescription drugs within 30 days 1988-2014
- U.S. population with usage of Rx drugs within 30 days by gender 1988-2014
- U.S. population with 3 or more prescriptions within 30 days by gender 1988-2014
- U.S. population with 5 or more prescriptions within 30 days by age 1988-2014
- U.S. top 20 branded drugs based on retail sales 2011
- Total U.S. population with 3 or more prescriptions within 30 days 1988-2014
- Psoriasis drugs market in the United States by therapy class 2016-2022
- R&D expenditure of Roche in Spain 2009-2015
- Manufacture of pharmaceutical preparations revenue in Belgium 2010-2022
- Level of confidence in medicine in France 2016, by type of drug
- Forecast: revenue basic pharmaceutical product manufacture Austria 2008-2020
Studies
- Recent Trends in Hospital Drug Spending and Manufacturer Shortages (2019)
- Prescribed Drug Spending in Canada, 2018
- Drug Use Among Seniors in Canada, 2016
- Meds Entry Watch 2017
- Trends in Retail Prices of Brand Name Prescription Drugs Widely Used by Older Americans: 2...
- Prescribed Drug Spending in Canada, 2017
- CDER 2018 New Drug Therapy Approvals
- Meds Entry Watch 2016
- Trends in Retail Prices of Prescription Drugs Widely Used by Older Americans: 2006 to 2015
- Compass Rx - Annual Public Drug Plan Expenditure Report 2015/16
- Prescription drug access and affordability an issue for nearly a quarter of all Canadian h...
- Patented Medicine Prices Review Board - Annual Report 2017
- CDER 2017 New Drug Therapy Approvals
- Compass Rx - Annual Public Drug Plan Expenditure Report 2012/13
- Prescribed Drug Spending in Canada, 2013
Statistics on "U.S. pharmaceutical industry"
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*
- Market share of top 10 national pharmaceutical markets worldwide in 2017*
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2017 (in billion U.S. dollars)
- Leading countries in global life sciences mergers and acquisitions based on deal number in 2018
- Total nominal spending on medicines in the U.S. from 2002 to 2016 (in billion U.S. dollars)*
- Top 20 U.S. therapy areas based on drug spending in 2016 (in billion U.S. dollars)
- Top 20 prescription drugs based on U.S. sales in 2016 (in billion U.S. dollars)*
- Top 20 U.S. pharma products by dispensed prescriptions in 2016 (in millions)
- Channel distribution of U.S. pharmaceutical spending from 2014 to 2016 (in billion U.S. dollars)
- U.S. pharmaceutical preparation manufacturing gross output from 1998 to 2016 (in million U.S. dollars)*
- U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)
- 2018 ranking of the top 10 U.S. biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)*
- Top 20 pharmaceutical corporations by U.S. revenue in 2016 (in billion U.S. dollars)*
- Johnson & Johnson's total revenue from 2005 to 2018 (in million U.S. dollars)
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)
- Total revenue of Merck & Co. from 2006 to 2018 (in million U.S. dollars)
- Advertising expenditure of selected pharmaceutical companies in the United States in 2015 (in thousand U.S. dollars)
- Top pharmaceutical company penalties in the United States between 2012 and 2015 (in million U.S. dollars)*
- Top 10 pharmaceutical companies in Canada in 2016, by revenue (in billion Canadian dollars)
- Research and development expenditure of total U.S. pharmaceutical industry from 1995 to 2017 (in billion U.S. dollars)*
- Spending of U.S. pharmaceutical industry for research and development as a percentage of total revenues from 1990 to 2017
- Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*
- Cost of developing a drug in the U.S. from the 1970s until today (in million U.S. dollars)*
- Number of new molecular entities launched in the U.S. from 2003 to 2015
- Number of FDA approved orphan designations in the United States from 2000 to 2014
- New medicine brands spending growth in the U.S. from 2011 to 2015 (in billion U.S. dollars)
- Pharmaceutical R&D expenditure per employee compared to other U.S. manufacturing sectors 2000-2014
- Change in branded and generic medication spending in the United States from 2013 to 2017 (in billion U.S. dollars)*
- Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016
- Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2016
- Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)
- Leading drugs going off patent in the U.S. in 2017, by revenue (in million U.S. dollars)*
- Projected revenue growth rates of the global pharmaceutical industry in the period 2015-2018, by region
- Forecast of global medicine spending distribution in 2020, by region*
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*
- Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*
- Projected top 25 pharmaceutical products by U.S. revenue in 2024 (in million U.S. dollars)
- Healthcare and pharmaceutical industry digital advertising spending in the United States from 2011 to 2019 (in billion U.S. dollars)
- How is your overall impression of the U.S. pharma industry?
- How high do you think the pressure on physicians is from the pharma industry to prescribe certain drugs?
- How would you rate the U.S. pharma companies concerning the quality of their drugs?
- How would you rate the U.S. pharma companies concerning their fairness towards patients?
- Percentage of Americans who would rate U.S. pharma companies excellent or good in selected features as of 2017
- Which of these pharma companies do you prefer when buying drugs?
- Opinion of Americans on U.S. pharmaceutical product quality compared to foreign products as of 2017*
- Top 10 prescription drugs based on U.S. market share in 2016 (in billion U.S. dollars)*
- Reduction in value due to expiring patents in the United States from 2016 to 2019 (in billion U.S. dollars)*
- Opinions on the quality of drugs made by U.S. pharma companies as of 2017, by ethnicity
- Patented drugs average price change in 2017, by country
- Patented drugs quantity changes in Canada between 2015 and 2016, by therapeutic class*
- Canada's share of global drug sales from 2005 to 2017
- Patented drugs sales changes in Canada during 2017 (in million Canadian dollars)
- Distribution of Canada's patented drug sales generated in 2017, by year of product introduction
- Patented drug sales impact on changes in expenditure in Canada by therapeutic class in 2017
- Percentage of total U.S. population with usage of prescription drugs within past month in periods between 1988 and 2014*
- Percentage of U.S. population with usage of prescription drugs within past month in periods between 1988 and 2014, by gender*
- Percentage of U.S. population with three or more prescriptions within past month in periods between 1988 and 2014, by gender*
- Percentage of U.S. population with 5 or more prescriptions within past month in periods between 1988 and 2014, by age group*
- U.S. top 20 branded drugs based on total retail sales in 2011 (in million U.S. dollars)
- Percentage of total U.S. population with 3 or more prescriptions within past month in periods between 1988 and 2014*
- Psoriasis drugs market in the United States from 2016 to 2022, by therapy class (in billion U.S. dollars)
- Research and development expenditure of Roche in Spain from 2009 to 2015 (in million euros)
- Manufacture of pharmaceutical preparations revenue in Belgium from 2010 to 2022 (in billion U.S. dollars)
- Share of French people to trust medicinal drugs in 2016, according to the type of medicine
- Revenue of basic pharmaceutical product manufacture (NACE Rev. 2 C2110) in Austria from 2008 to 2020 (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.